Litcius/Paper detail

Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial

Payam Tabarsi, Saghar Barati, Hamidreza Jamaati, Sara Haseli, Majid Marjani, Afshin Moniri, Zahra Abtahian, Alireza Dastan, Sahar Yousefian, Raha Eskandari, Ali Saffaei, Fateme Monjazebi, Arshia Vahedi, Farzaneh Dastan

2020International Immunopharmacology87 citationsDOIOpen Access PDF

Topics & Concepts

MedicineHydroxychloroquineLopinavirRandomized controlled trialMechanical ventilationIntensive care unitInternal medicineCoronavirus disease 2019 (COVID-19)PediatricsAnesthesiaEmergency medicineDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and Thrombosis
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial | Litcius